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Background: Newborns with obstructive left heart lesions often depend on a patent ductus arteriosus to sustain
the systemic circulation. Our aims were to validate the direct measurement of ductal flow, and to characterize the
magnitude, determinants and hemodynamic effects of patent ductus arteriosus in newborns with obstructive left
heart lesions by cardiovascular magnetic resonance (CMR).
Methods: In this retrospective study, the CMR and clinical information of newborns with obstructive left heart
lesions were reviewed. The feasibility and validity of measuring ductal flow and the correlations between ductal
flow and ventricular volumes, ascending aortic flow, post-ductal oxygen saturation and Qp:Qs were assessed.
Results: The CMR examinations of 32 newborns were included. It was possible to measure the ductal flow in all of
them, with moderate-to-good agreement between measured and calculated ductal flow volume. The flow was
bidirectional in all patients, with a net right-to-left shunt in 72%. Net ductal flow correlated inversely with ascending
aortic flow (Rho −0.63; p 0.0002), post-ductal oxygen saturation (Rho −0.58; p 0.0004), Qp:Qs (Rho −0.43; p 0.02), and
with left ventricular end-diastolic volume index (Rho −0.38; p 0.04). There was no correlation with the diameter of
the ductus. The contribution of ductus flow to the systemic circulation correlated with the left ventricular
end-diastolic volume index (Rho −0.47; p 0.02).
Conclusions: Direct measurement of ductal flow in newborns with obstructive left heart lesions is feasible. From
these measurements, we were able to demonstrate that patients with smaller left ventricles and lower ascending
aortic flow have a greater contribution of ductal flow to the systemic circulation. The size of the ductus arteriosus
does not predict net ductal flow. Phase-contrast CMR can be an adjunct method for the assessment of the
physiology for very ill neonate patients.
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Congenital heart diseaseBackground
Newborns with significant congenital obstructive left
heart lesions (OLHL), including hypoplasia of the left
ventricle (LV), severe aortic valve stenosis and aortic
arch obstructions, frequently rely on the contribution of
blood flow via the patent ductus arteriosus (PDA) to the
systemic circulation. In the medical and surgical man-
agement of these patients it is important to know to* Correspondence: lars.grosse-wortmann@sickkids.ca
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reproduction in any medium, provided the orwhat extent the systemic circulation depends on the
contribution from flow through the PDA and what the
relation of pulmonary to systemic blood flow (Qp:Qs)
is [1-3].
In clinical practice, shunt magnitude and net flow dir-
ection are typically estimated by semiquantitative ultra-
sound assessment, including measurements of ductal
size, “eyeballing” of the color Doppler profile, and inter-
pretation of pulsed or continuous wave Doppler flow
profiles [4]. Velocity mapping using “through-plane”
phase contrast cardiovascular magnetic resonance (PC-
CMR) is the gold-standard for non-invasive flowtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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orientation, including the arterial duct, can be evaluated
for blood flow velocity, volume and pattern. PC-CMR
has been routinely used in patients with congenital heart
diseases for the assessment of blood flow, including
shunting quantification [5,8].
The aims of the current study were to validate the dir-
ect measurement of ductal flow, characterize the magni-
tude, the determinants and the hemodynamic and
clinical effects of flow through the PDA in newborns
with OLHL by CMR.
Methods
Following approval by the Hospital for Sick Children re-
search ethics board, the imaging studies and clinical in-
formation of all newborns with OLHL who were on a
prostaglandin infusion and underwent CMR during the
first month of life, prior to any kind of intervention to
alleviate the obstruction between August 2003 and July
2011 were retrospectively reviewed.
CMR was performed on a 1.5 Tesla scanner (“GE signa
CV/I”, General Electric Medical Systems, Milwaukee,
WI, USA, before July 2007; and “Avanto”, Siemens Med-
ical Solutions, Erlangen, Germany, thereafter), using
head-and-neck coils. PC-CMR datasets were acquired
using retrospective ECG-gating, during free-breathing or
continued mechanical ventilation under sedation, and
applying the following settings: Slice thickness (4 mm),
in-plane spatial resolution of 1 × 1 mm, temporal reso-
lution sufficient to acquire at least 20 true phases per
cardiac cycle, 2 averages, minimum echo and repetition
times, and flip angle of 15–30°. The velocity encoding
limit varied between 150–400 cm/s and was chosen
according to the vessel of interest: lower velocities forFigure 1 Magnitude and phase images of through-plane phase-contras
aortic arch; LPA = left pulmonary artery).veins and higher velocities for arteries. The typical ac-
quisition time for each PC-CMR sequence scan time
was 90 seconds.
PDA flow was captured by acquiring PC-CMR velocity
data in the short axis of the vessel (Figures 1 and 2). The
imaging slice was positioned using multiplanar reformats
of a three-dimensional contrast-enhanced angiographic
dataset. In addition, flows in the superior vena cava
(SVC); ascending (AAo) and descending aorta (DAo);
main pulmonary artery (MPA), left (LPA) and right
(RPA) branch pulmonary arteries were obtained. For the
purpose of this study, all flows were reanalyzed on a
commercially available work station (QFlow 5.2; Medis
Medical Imaging Systems, Leiden, The Netherlands).
The durations of antegrade (right-to-left) and retrograde
(left-to-right) flows across the PDA were measured from
the flow-time curves generated from the PC-CMR data.
Their relation was termed antegrade/retrograde duration
ratio (AR ratio).
These measurements were used for calculating sys-
temic (Qs) and pulmonary (Qp) flows, using the follow-
ing equations:
Qs ¼ SVCþ DAo ð1Þ
Qp ¼ RPAþ LPA ð2Þ
In order to internally validate the measured PDA flow,
it was also calculated by the following two methods:
PDA ¼ Qsþ −AAo ð3Þ
PDA ¼ MPA– Qpð Þ ð4Þ
The largest ductal diameter during the cardiac cycle
was measured on cross-sectional cine images. Left andt imaging of the patent ductus arteriosus (PDA) (Ao = transverse
Figure 2 Flow volume curve across the patent ductus arteriosus in a patient with mitral stenosis and aortic valve atresia, showing
bidirectional flow.
Table 1 Demographic and clinical information
All patients (n = 32)
Gender 21 male (65.6%)
Age 4.3 ± 3.2 (0–13) days
Weight 3.12 ± 0.57 (1.70 – 4.44) Kg
Body surface area 0.21 ± 0.03 (0.14 – 0.26) m2
PDA diameter 7.0 ± 1.6 (3.8 – 11.5) mm
Post-ductal O2 saturation 91 ± 6 (74 – 99)%
Heart rate 131 ± 17 (98 – 164) bpm
PDA patent ductus arteriosus.
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measured from a stack of short axis cine images which
were analyzed using commercially available software
(Mass Analysis and QMass 7.2, both Medis Medical Im-
aging Systems). Flow and volumetric measurements
were standardized to body surface area using Mosteller’s
formula: BSA = {[Height (cm) × Weight (Kg)]/3600}1/2.
By definition, negative flow denoted a left-to-right flow
across the PDA.
Patients’ demographics and clinical information were
retrieved from the medical records.
Statistical analyses
All statistical analyses were conducted using the soft-
ware StatsDirect, version 2.7.2. 2008 (Cheshire, United
Kingdom).
Spearman’s rank correlation (Rho) was calculated to
assess the relation between flow measurements by PC-
CMR and clinical variables. T-tests were used to com-
pare continuous numeric data of subgroups. Categorical
variables were expressed using frequency distribution
and percentages, and comparisons were made using the
Fisher exact test. Bland-Altman analyses were used to
express the agreement between direct measurements of
PDA flow and calculated PDA flow as per Equations 3
and 4. P values < 0.05 were considered significant.
Results
Thirty-two newborns with OLHLs were included. The
patients’ demographic information and clinical parame-
ters are outlined in Table 1. All patients received a
contiuous infusion of prostaglanding during the examin-
ation. In 25 out of the 32 patients the exam was
performed under mechanical ventilation and general
anesthesia. Five were sedated with propofol, but notintubated and two underwent a feed-and-sleep approach.
There were 23 cases with mitral valve stenosis and / or
mitral hypoplasia. Of these 23, 19 had aortic valve sten-
osis, 16 had coarctation of the aorta, four had aortic
valve atresia, and four had ventricular septal defects.
One patient had mitral and aortic valve atresia and one
patient had an unbalanced atrioventricular septal defect
with right ventricular dominance and hypoplastic aortic
arch. Of the remaining seven patients with normal mi-
tral valves, five had aortic valve stenosis (three with co-
arctation of the aorta and one with type B interruption
of the aortic arch), one case had isolated coarctation of
the aorta and one presented with an obstructive tumor
in the LV. The reasons for CMR were: to assess the vol-
ume of the LV and antegrade flow through the AAo for
surgical decision-making between bi- and univentricular
repair in 28 cases, to assess the morphology and extent
of a cardiac tumor in one case, to aid in planning bal-
loon dilatation of the aortic valve in one case, to better
define the pulmonary venous connection in one case
and to better visualize the aortic arch in another case.
CMR measurements are presented in Table 2. The
flow was bidirectional in all patients, and net PDA flow
Table 2 CMR findings
Variables All patients Patients with net RL shunt Patients with net LR shunt P
LVEDVi (ml/m2) 25.8 ± 10.9 (11.8 - 71.2) 24.9 ± 12.6 (11.8 - 71.2) 27.8 ± 5.5 (21–35.2) 0.40
RVEDVi (ml/m2) 77.3 ± 26.4 (41.6 – 140.5) 81.8 ± 26.8 (47 – 140.5) 66.3 ± 23.6 (41.6 – 106) 0.16
LV/RV volume 0.39 ± 0.27 (0.1 - 1.51) 0.36 ± 0.3 (0.1 - 1.51) 0.47 ± 0.16 (0.26 – 0.71) 0.33
RVEF (%) 49.1 ± 9.1% (28 – 67) 49 ± 8.8% (28 – 62) 49.3 ± 10.7% (31–53) 0.94
LVEF (%) 59.4 ± 11.5% (36 – 81) 58.2 ± 11.1% (36 – 81) 62.3 ± 12.7% (36 – 77) 0.38
PDA flow* (L/min/m2) 0.86 ± 1.20 (−1.48 – 3.24) 1.44 ± 0.83 (0.04 – 3.24) −0.62 ± 0.49 (−1,48 – -0.04) < 0.0001
AAo flow (L/min/m2) 1.39 ± 0.99 (−0.19 – 2.96) 1.08 ± 0.85 (−0.19 – 2.41) 2.24 ± 0.88 (0.32 – 2.96) 0.003
SVC flow (L/min/m2) 1.37 ± 0.5 (0.46 – 2.93) 1.5 ± 0.51 (0.63 – 2.93) 1 ± 0.23 (0.46 – 1.22) 0.001
DAo flow (L/min/m2) 1.03 ± 0.48 (0.3 – 2.42) 1.13 ± 0.5 (0.3 – 2.42) 0.76 ± 0.26 (0.41 – 1.24) 0.06
Pulmonary flow (RPA + LPA) (L/min/m2) 4.22 ± 1.79 (1.62 – 7.39) 4.14 ± 1.71 (1.62 – 7.14) 4.41 ± 2.1 (1.82 – 7.39) 0.72
Systemic flow (SVC + DAo) (L/min/m2) 2.4 ± 0.94 (0.93 – 5.35) 2.66 ± 1 (0.93 – 5.35) 1.75 ± 0.23 (1.41 – 2.05) 0.02
Qp:Qs 2.2 ± 1.34 (0.38 – 5.82) 2.04 ± 1.36 (0.38 – 5.82) 2.57 ± 1.29 (0.89 – 4.26) 0.36
Contribution of PDA to Qs (%) 27.7 ± 48.3% (−87† – 100) 52.5 ± 26.8% (4.7 – 100) −34.2 ± 29.9% (−87.2 – -2.39) < 0.0001
Contribution of PDA to DAo (%) 41.7 ± 74.7% (−100† – 100) 81.7 ± 31.9% (5.2 – 100) −63.2 ± 44.9% (−100 – -5.29) < 0.0001
Upper body flow% 57.7 ± 8.2% (27.1 – 70.9) 57 ± 5.3% (46.7 – 67.7) 60.5 ± 13.4% (27 – 70.9) 0.96
AR ratio 0.59 ± 0.17 (0.28 – 0.92) 0.66 ± 0.14 ( (0.45-0.92) 0.40 ± 0.09 (0.28 – 0.52) < 0.0001
*negative values denote a left-to-right shunt.
†negative percentages denote a contribution of aortic arch flow to pulmonary blood flow via a left-to-right shunt across the PDA.
AAo ascending Aorta, AR ratio antegrade/retrograde duration ratio, DAo descending Aorta, LPA left pulmonary artery, LV left ventricle, LVEDVi LV end-diastolic
volume index, LVEF LV ejection fraction, PDA patent ductus arteriosus; Qp:Qs pulmonary flow: systemic flow, RPA right pulmonary artery, RV right ventricle, RVEDVi
RV end-diastolic volume index, RVEF RV ejection fraction, SVC superior vena cava.
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72%). It was possible to quantify the PDA flow in all pa-
tients. Measured PDA flow correlated very well with the
calculated PDA flow using Equation 3 (Rho = 0.90, p <
0.0001), and moderately well with the calculated PDA
flow using Equation 4 (Rho = 0.73, p = 0.001). However,
by using Bland-Altman analysis the variability of
measurements were found wide by both Equation 3
(Bias SD = −0.08 L/min/m2; limits of agreement 95% =
−1.27 to 1.10 L/min/m2, Figure 3) and Equation 4 (Bias
SD = 0.22 L/min/m2; limits of agreement 95% = −1.32 to
1.75 L/min/m2, Figure 4).
PDA net flow correlated strongly with the AR ratio
(Rho = 0.88; p < 0.0001), inversely with the amount of
AAo flow (Rho = −0.63; p = 0.0002), post-ductal oxygen
saturation (Rho = −0.58; p = 0.0004), Qp:Qs (Rho = −0.43;
p = 0.02), and LVEDVi (Rho = −0.38; p = 0.04). There
were no statistically significant correlations of PDA net
flow volume with PDA diameter, whether the latter was
indexed or not to body surface area (Rho = 0.26; p = 0.15
for both) or right ventricular end-diastolic volume index
(Rho = 0.21; p = 0.29).
Three patients did not undergo ventricular volumetry.
Out of the other 29 patients, seven had a LVEDVi of less
than 20 ml/m2. All patients with LVEDVi < 20 ml/m2
presented with a net right-to-left flow across the PDA,
while nine out of the other 22 patients (41%) had a net
left-to-right flow across the PDA (p = 0.05). Patientswith LVEDVi < 20 ml/m2 had a greater mean right-to-left
shunt than patients with larger LV’s (1.65 ± 0.49 L/min/m2
vs 0.46 ± 1.21 L/min/m2, respectively, p = 0.001) as well as
a greater contribution of the PDA flow to the systemic cir-
culation than those with bigger ventricles (61.7 ± 19.3%%
vs 16.4 ± 50.0%; p = 0.002). LVEDVi correlated with as-
cending aortic flow (Rho = 0.44; p = 0.02).
The contribution of PDA flow to the systemic circula-
tion varied between −87% and 100% (Table 2; negative
values represent left-to-right shunting across the PDA).
There was a strong positive correlation between this
contribution and the AR ratio (Rho = 0.83; p < 0.0001),
and a negative correlation between this contribution and
flow in the ascending aorta (Rho = −0.73; p < 0.0001),
and also with LVEDVi (Rho = −0.47; p = 0.02). There
was no correlation between the contribution of the PDA
flow to the systemic circulation and PDA diameter,
either in absolute diameter measurements (Rho = 0.21;
p = 0.26) or indexed to body surface area (Rho = 0.17;
p = 0.39).
Post-ductal oxygen saturation correlated with Qp:Qs
(Rho = 0.49; p = 0.009) and inversely with the contri-
bution of PDA flow to the descending aortic flow
(Rho = −0.45; p = 0.008). Relative upper body perfusion,
measured as the percentage of superior vena cava flow
over total systemic flow, did not correlate with PDA net
flow (Rho = −0.26; p = 0.17), or with antegrade ascending





































Mean PDA flow measured and calculated
Bias SD: -0.08 L/min/m2 
Limits of agreement (95%): -1.27 to 1.1 L/min/m2 
Figure 3 Bland-Altmann plot for PDA flow measured and calculated as per Equation 3 (PDA = Qs – AAo).
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http://www.jcmr-online.com/content/15/1/45An AR ratio ≥ 0.45 identified cases with a net right-
to-left shunt with a sensitivity of 100% and a specificity
of 88%. For an AR ratio ≥ 0.53 the sensitivity and specifi-
city were respectively 79.2% and 100%.
In the subgroup of 23 patients with a net right-to-left
shunt, ductal flow correlated weakly with ascending aortic
flow (Rho = −0.43; p = 0.04), and PDA diameter (Rho =
0.42; p = 0.04). There was no correlation between the-1.5 -1 -0.5 0 0.5
Mean PDA flow measu
Bias SD: 0.
Limits of ag
Figure 4 Bland-Altmann plot for PDA flow measured and calculated acontribution of the PDA flow to the systemic circulation
and PDA diameter (Rho = 0.26; p = 0.31).
Following CMR, 6 patients underwent a staged
univentricular repair while a biventricular circulation
was targeted in 24. Two received compassionate care.
CMR results for the univentricular and biventricular re-
pair groups, respectively are presented in Table 3. Pa-









































reement (95%): -1.32 to 1.75 L/min/m2 
s per Equation 4 (PDA = MPA – QP).
Table 3 CMR findings of patients according to the type of treatment: univentricular or biventricular
Variables Univentricular Biventricular P
PDA flow* (L/min/m2) 1.70 (0.56 to 2.53) 0.61 (−1.48 to 3.23) 0.0147
AAo flow (L/min/m2) 0.56 (−0.19 to 1.08) 1.82 (−0.16 to 2.92) 0.0006
Contribution of PDA to Qs (%) 56.59 (39.77 to 100) 24.14 (−87.16 to 100) 0.0013
LVEDVi (ml/m2) 15.75 (11.8 to 30.3) 27 (17.7 to 71.2) 0.024
AR ratio 0.72 ± 0.14 (0.52 to 0.92) 0.54 ± 0.17 (0.28 to 0.89) 0.01
*negative values denote a left-to-right shunt.
†negative percentages denote a contribution of aortic arch flow to pulmonary blood flow via a left-to-right shunt across the PDA.
AAo ascending Aorta, AR ratio antegrade/retrograde duration ratio, LVEDVi LV end-diastolic volume index, PDA patent ductus arteriosus.
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to-left shunting across the PDA and had smaller left
ventricles than those who underwent a biventricular re-
pair. At the time of manuscript completion, 25 of 32
were alive. Of the 7 patients who died, 2 had received
compassionate care, 3 had been treated with a
univentricular and 2 with a biventricular approach.
Discussion
Many patients with OLHL depend on PDA flow to sus-
tain, partially or completely, the systemic circulation.
Consequently, the ability to assess not only the cardiac
anatomy, but also the functional status of the ductus
arteriosus is important in the care of these patients.
With this study we introduce direct measurements of
ductal flow by PC-CMR and examine the determinants
of ductal blood flow amount.
PDA flow can be measured by CMR
In a study limited to systemic perfusion in preterm and
term newborns, Groves and colleagues obtained more
complete data with a greater reproducibility using CMR
than existing echocardiographic methods [9]. In simple
intracardiac shunt lesions, PC-CMR based quantification
of Qp:Qs has shown excellent agreement with invasive
oximetry [10-12]. Selective vessel assessments allow for
shunt quantification in complex cases of congenital
heart diseases, including patients with univentricular
physiology [13-16], thus providing key information for
invasive management decisions in very ill neonates [17].
In principle, it is possible to derive PDA flow in three
different ways: 1) By direct measurement, 2) as the
difference between LV cardiac output (AAo flow) and
perfusion to the upper (SVC flow) and lower body (DAo
flow), and 3) by subtracting branch pulmonary artery
flows from main pulmonary artery flow. Recently,
Broadhouse and colleagues [18], studying otherwise
healthy neonates, quantified PDA flow volume by
subtracting ascending aortic flow from Qs, similar to
Equation 3 used here. The authors judged direct meas-
urement of PDA to be technically not feasible due to thevariable and unfavorable morphology. However, in neo-
nates with OLHL, the duct tends to be straight, of con-
siderable length and often large. In our experience,
prescription of the appropriate PC acquisition is typically
straightforward, provided that thin enough slices are
used. In the present study, the directly measured PDA
flow correlated very well with the PDA flow derived
using Equation 3 (PDA = SVC + DAo – AAo). The
weaker correlation with Equation 4 [PDA = MPA –
(RPA + LPA)], might be related to inaccuracy of the flow
measurements in the large main pulmonary artery with
high volume flow. Nevertheless, the wide limits of agree-
ment reflect considerable differences in results using
measured PDA flow on the one hand and calculated
flow on the other. In the absence of an independent gold
standard, it is difficult to be affirmative about the accur-
acy of either method. However, on PC-CMR acquisitions
(Figure 1) the PDA appears similar to other arteries like
the aorta and the branch pulmonary arteries. As such,
assessment of PDA flow based on single, direct measure-
ments may well be more accurate than a composite cal-
culation from three different methods, each with its own
errors.
PDA flow direction and magnitude, and contribution of
ductal flow to the systemic circulation
PDA flow was bidirectional in all patients, with a net
right-to-left shunt in the majority. The contribution of
the ductal flow to the systemic circulation was up to
100%. Interestingly, in nine patients the PDA net flow
was from the systemic to the pulmonary circulation,
which could have influenced the management by leading
to cessation of the prostaglandin infusion, as the PDA
was not needed to supplement the systemic circulation.
The LVEDVi in these nine patients was significantly
greater than in the other patients with a right-to-left
shunt across the PDA (Table 2).
As expected, more right-to-left flow across the PDA
resulted in lower post-ductal oxygen saturations and
lower Qp:Qs. PDA flow also correlated inversely with
antegrade flow through the ascending aorta, LV/RV ratio
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less than 20 ml/m2, one of the parameters commonly
used in surgical decision making between uni- or
biventricular repair [19,20], presented with a significantly
greater amount of right-to-left flow through the PDA
than those with bigger ventricles. Clinically and patho-
physiologically, these findings feed into the expectation
that patients with larger LVs and greater antegrade flow
in the ascending aorta rely less on a contribution from
PDA flow to the systemic circulation.PDA size is a poor predictor of shunt magnitude
Intuitively, a large caliber PDA suggests a large amount
of flow. However, in the overall cohort of patients, we
did not find a correlation between PDA diameter and
shunt magnitude, or contribution of PDA flow to the
systemic circulation. In the patients with a net right-to-
left shunt across the duct its size correlated with the net
shunt amount, but the correlation was weak and is un-
likely to be helpful in gauging the PDA contribution to
the systemic circulation in a clinical setting.
These results suggest that PDA size may be simply a
consequence of pendular flow, i.e., alternating forward
and backward flow, rather than net flow. The same
mechanism of dilatation through pendular flow is found
in patients with absent pulmonary valve syndrome.
There was a strong positive correlation of the duration
of right-to-left (antegrade) flow, relative to the left-to-
right flow duration, with PDA net right-to-left flow and
with the contribution of PDA flow to the systemic flow.
Hence, a longer relative antegrade flow duration allows
more right-to-left shunt across the PDA. Even in the ab-
sence of a full hemodynamic assessment by CMR, the
AR ratio may add to the identification of duct-
dependency in patients with OLHL. We hypothesize that
AR ratio, which is also obtainable by echocardiography,
may become a suitable marker for LV output in patients
with OLHL and for the degree of contribution of PDA
flow to the systemic circulation.CMR results and patients outcomes
Although this was a retrospective study and not aimed
at assessing the significance of PDA flow for patient out-
comes, it is interesting to note that patients who went
on to undergo a univentricular repair strategy depended
more on PDA flow for their systemic perfusion, had a
greater degree of right-to-left shunt and smaller LVs. As
PDA flow was not directly used for surgical decision-
making it is tempting to speculate that patients who
have greater ascending aortic flow and rely less on PDA
flow for Qs are more likely to be subject to a
biventricular repair strategy.Study limitation
The limited cohort size may have obscured certain asso-
ciations between parameters. As the data was collected
retrospectively, the patient’s clinical data was limited
to what was recorded at the time of CMR, as the
hemodynamic physiology in OLHL is often labile and as-
sociations with clinical parameters outside of the CMR
study were deemed to be unreliable. It would have been
interesting to demonstrate that the AR ratio measured
by CMR can be substituted by a similar measurement
by Doppler echocardiography. However, our review of
oxygen saturations and ventilation parameters showed
that the physiology during the echocardiogram closest to
the CMR was significantly different to that during the
CMR study which prohibited a comparison of the two
modalities.
Conclusions
Direct and indirect assessments of ductal flow in new-
borns with obstructive left heart lesions are feasible. Pa-
tients with OLHL present with a wide spectrum of PDA
flow magnitude. Those with smaller left ventricles and
ascending aortic blood flow rely more on the contribu-
tion from PDA flow to the systemic circulation.
Ductal flow, and its contribution to the systemic circu-
lation, cannot be inferred reliably from PDA size. In pa-
tients in whom net PDA flow is a component of medical
or surgical decision making direct measurement of
ductal blood flow by CMR should be considered.
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